Eastman Chemical Stock Hits New 52-Week High (EMN)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Eastman Chemical Company (NYSE: EMN) hit a new 52-week high Friday as it is currently trading at $64.74, above its previous 52-week high of $64.64 with 397,007 shares traded as of 10:45 a.m. ET. Average volume has been 1.6 million shares over the past 30 days.

Eastman Chemical has a market cap of $9.76 billion and is part of the basic materials sector and chemicals industry. Shares are up 63% year to date as of the close of trading on Thursday.

Eastman Chemical Company, a chemical company, engages in the manufacture and sale of chemicals, plastics, and fibers in the United States and internationally. The company has a P/E ratio of 16.7, below the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Eastman Chemical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. You can view the full Eastman Chemical Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

Holiday Special: Subscribe to Action Alerts PLUS to see how Jim Cramer trades his $2.5 Million+ portfolio for 51% off the list price. Your first 14-days are FREE: Sign up today to get e-mail alerts before every trade.
null

If you liked this article you might like

Market Recon: The Tax Reform Is Just Ordinary Negotiation on Steroids

Are Trump Stocks a Crowded Trade?

Avangrid Chart Shows Good Fundamentals Not Everything in Trading

Here's Why These 3 Stocks With Alluring Dividends Are Strong Buys

Bullish and Bearish Reversals for the Week